Nasdaq grants biomerica an additional 180 days to meet listing compliance requirements

Irvine, calif., nov. 07, 2024 (globe newswire) -- biomerica, inc. (nasdaq: bmra), a leading global provider of advanced medical diagnostics, announced that it has been granted an additional 180-day compliance period from the nasdaq stock market llc ("nasdaq") to meet the minimum $1.00 per share bid price requirement for continued listing on the nasdaq capital market. this extension allows biomerica until may 5, 2025, to regain compliance.
NDAQ Ratings Summary
NDAQ Quant Ranking